Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹100

AUM (Fund size)

2,031 Cr

Lock In Period

N/A

Expense Ratio

2.09

Benchmark

BSE Healthcare

Exit Load

In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.

Summary

Latest details for HDFC Pharma and Healthcare Fund Growth include a 17.53 NAV as of Mar 12,2026 and returns since inception of --%. Minimum investments start at SIP ₹100. The HDFC Pharma and Healthcare Fund Growth AUM is ₹2,031 Cr, with a lock-in of N/A years, expense ratio of 2.09%, and benchmark BSE Healthcare. Exit load is - In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.. In the growth review for 1M Month/Year, the fund recorded 1.10% returns, against a category average of -1.54% and a category best of 13.36%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M1.10-1.5413.36
6M1.251.4044.88
1Y16.865.97121.64
3Y0.0014.35230.94

Portfolio Analysis

  • Equity: 97.34%
  • Debt: 2.66%
  • Others
As on: 2026-01-31
View allocation % by

1. Sun Pharmaceutical Industries Ltd.9.75%
2. Divis Laboratories Ltd.8.57%
3. Glenmark Pharmaceuticals Ltd.6.76%
4. Lupin Ltd.6.52%
5. Alkem Laboratories Ltd.6.42%
6. Ipca Laboratories Ltd.5.00%
7. Torrent Pharmaceuticals Ltd.4.24%
8. Anthem Biosciences Limited4.05%
9. Acutaas Chemicals Limited3.46%
10. Laurus Labs Ltd.2.83%
11. Eris Lifesciences Ltd2.50%
12. Wockhardt Ltd.1.90%
13. Jubilant Pharmova Limited1.66%
14. Sai Life Sciences Limited1.64%
15. Shilpa Medicare Ltd1.56%
16. Gland Pharma Ltd.1.23%
17. Rubicon Research Limited1.16%
18. BAJAJ HEALTHCARE LIMITED1.05%
19. CORONA REMEDIES LIMITED0.56%

1. Max Healthcare Institute Limited6.03%
2. Fortis Healthcare Limited3.82%
3. Krishna Institute Of Medical Sciences Limited3.17%
4. Aster DM Healthcare Limited3.16%
5. Metropolis Healthcare Ltd.2.70%
6. Vijaya Diagnostic Centre Limited2.37%
7. Dr. Lal Path Labs Ltd1.77%
8. Thyrocare Technologies Ltd.1.61%
9. Global Health Limited1.20%

About Fund

HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹2,031 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.09. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundMotilal Oswal Digital India Fund Growth-5.74890
This FundUnion Innovation & Opportunities Fund Growth7.0470
This FundHDFC Pharma and Healthcare Fund Growth16.86450
This FundICICI Prudential PSU Equity Fund Growth19.4185105.7656
This FundNippon India Taiwan Equity Fund Growth118.586217.4449

FAQs

HDFC Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of HDFC Pharma and Healthcare Fund Growth is 2.09. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

HDFC Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 1.10%
  • 6 Months : 1.25%
  • 1 Year : 16.86%
  • 3 Years : 0.00%
Returns of HDFC Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 17.53 as on Mar 12,2026. Since inception, the return has been 0.00%.

You can invest in HDFC Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of HDFC Pharma and Healthcare Fund Growth is ₹2,031 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in HDFC Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500